DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR LORATADINE AND PSEUDOEPHEDRINE SULFATE

« Back to Dashboard

All Clinical Trials for Loratadine And Pseudoephedrine Sulfate

Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00837915	Bioequivalnce Study of Loratadine / Pseudoephedrine Sulfate 10/ 240 mg Extended-Release Tablets Under Fasting Conditions	Completed	Ranbaxy Laboratories Limited	N/A	2002-06-01	The objective of this study was to compare the single-dose relative bioavailability of Ranbaxy and Schering (Claritin-D® 24 hour) Loratadine 10mg /Pseudoephedrine Sulfate 240 mg Extended-Release Tablets, in a fully replicated design, under fasting conditions.
NCT00845546	Bioequivalence Study of Loratadine / Pseudoephedrine Sulfate 10/ 240 mg Extended-Release Tablets Under Fed Conditions	Completed	Ranbaxy Laboratories Limited	N/A	2002-06-01	The objective of this study was to compare the single-dose relative bioavailability of Ranbaxy and Schering (Claritin-D® 24 hour) 10 mg Loratadine/240 mg Pseudoephedrine Sulfate Extended-Release Tablets, in a fully replicated design, under fed conditions.
NCT01055756	Clinical Trial Of The Effectiveness Of The Product Cloratadd D (Loratadine + Pseudoephedrine Sulfate) Produced By The Laboratory EMS S/A, Compared To The Drug Claritin D Produced By Schering-Plough S/A, In Patients With Allergic Rhinitis	Withdrawn	Azidus Brasil	Phase 3	2010-01-01	The primary objective of this study is to evaluate the clinical efficacy of the drug Cloratadd D ® (loratadine + pseudoephedrine sulfate - EMS S/A) compared to the drug Claritin D ® (loratadine + pseudoephedrine sulfate - Schering Plough) in patients with allergic rhinitis by quantification of the scores of clinical parameters (signs and symptoms) and laboratory (nasal flow) down through time.
NCT03443843	A Study to Evaluate Changes in Nasal Airflow of Loratadine/Pseudoephedrine Tablet and Fluticasone Propionate Nasal Spray in Subjects Following Allergen Exposure	Completed	Bayer	Phase 4	2018-02-21	The purpose of the study is to evaluate changes in nasal airflow caused by loratadine 5 mg/pseudoephedrine sulfate 120 mg (Claritin D) tablet and fluticasone propionate 50 mcg per spray nasal spray (Flonase) in subjects suffering from nasal congestion and other allergy symptoms.
NCT03517930	A Manufacturing Transfer Study Comparing the Bioequivalence of a Single Oral Dose of Claritin-D 12-Hour Extended Release Tablet From 2 Different Manufacturers Under Fasted Conditions in Healthy Adult Subjects	Completed	Bayer	Phase 1	2018-04-17	To evaluate the bioequivalence of one extended release combination (loratadine 5 mg/pseudoephedrine sulfate 120 mg) tablet manufactured for Bayer HealthCare LLC by SAG Manufacturing, S.L.U. Madrid, Spain (test treatment) to the extended release combination (loratadine 5 mg/pseudoephedrine sulfate 120 mg) tablet manufactured for Bayer SA-NV by Schering-Plough Labo NV Heist (reference treatment) which is currently marketed in Europe.
NCT03517943	A Manufacturing Transfer Study Comparing the Bioequivalence of a Single Oral Dose of Claritin-D 12-Hour Extended Release Tablet From 2 Different Manufactuers Under Fed Conditions in Healthy Adult Subjects	Completed	Bayer	Phase 1	2018-04-24	To evaluate the bioequivalence of one extended release combination (loratadine 5 mg/pseudoephedrine sulfate 120 mg) tablet manufactured for Bayer HealthCare LLC by SAG Manufacturing, S.L.U. Madrid, Spain (test treatment) to the extended release combination (loratadine 5 mg/pseudoephedrine sulfate 120 mg) tablet manufactured for Bayer SA-NV by Schering- Plough Labo NV Heist (reference treatment) which is currently marketed in Europe.

Clinical Trial Conditions for Loratadine And Pseudoephedrine Sulfate

Condition Name

Condition Name for Loratadine And Pseudoephedrine Sulfate
Intervention	Trials
Healthy	2
Clinical Pharmacology	2
Allergic Rhinitis	1
Rhinitis, Allergic	1

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Loratadine And Pseudoephedrine Sulfate
Intervention	Trials
Rhinitis	2
Rhinitis, Allergic	2

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Loratadine And Pseudoephedrine Sulfate

Trials by Country

Trials by Country for Loratadine And Pseudoephedrine Sulfate
Location	Trials
Canada	3
United States	2
Brazil	1

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Loratadine And Pseudoephedrine Sulfate
Location	Trials
New Jersey	2

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Loratadine And Pseudoephedrine Sulfate

Clinical Trial Phase

Clinical Trial Phase for Loratadine And Pseudoephedrine Sulfate
Clinical Trial Phase	Trials
Phase 4	1
Phase 3	1
Phase 1	2

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Loratadine And Pseudoephedrine Sulfate
Clinical Trial Phase	Trials
Completed	5
Withdrawn	1

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Loratadine And Pseudoephedrine Sulfate

Sponsor Name

Sponsor Name for Loratadine And Pseudoephedrine Sulfate
Sponsor	Trials
Bayer	3
Ranbaxy Laboratories Limited	2
Azidus Brasil	1

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Loratadine And Pseudoephedrine Sulfate
Sponsor	Trials
Industry	6

Export unavailable in trial.
Subscribe for complete access.